top of page

As CDMO's around the globe seek to optimize the operational process of Molecule scoring via Artificial intelligence (AI).


At Brick Lane we believe that Molecule scoring combined with Salesforce Einstein AI can provide operational efficiencies. However, the question is how do you achieve this?


The process of discovering and developing a new drug is complex, time-consuming, and resource-intensive. It involves extensive research and development, spanning laboratory experiments, preclinical studies, and rigorous clinical trials to ensure the safety and efficacy of the potential drug candidate.


Among the pivotal stages of drug development is molecule scoring, where various criteria are evaluated to assess the potential of a molecule to become a successful therapeutic agent. In recent years, the integration of AI technologies has emerged as a game-changer in optimizing this process.


Leveraging AI, particularly through platforms like Salesforce Einstein AI, holds the promise of streamlining and enhancing the efficiency of molecule scoring in drug discovery. Here, we delve into how organizations can harness the power of Salesforce Einstein AI to optimize their operational processes in discovering new drugs.


Understanding Molecule Scoring:

Molecule scoring is a critical phase in drug discovery where potential drug candidates are evaluated based on a multitude of factors. These factors encompass biological activity, selectivity, pharmacokinetics, pharmacodynamics, chemical properties, synthesis feasibility, intellectual property potential, and regulatory considerations.


Each criterion plays a crucial role in determining the viability of a molecule as a therapeutic agent. Traditionally, assessing these factors has been a laborious and time-consuming task, often reliant on manual analysis and subjective judgment.


Leveraging Salesforce Einstein AI:

Salesforce Einstein offers a suite of AI-powered tools designed to analyze data, derive insights, and make predictions, thereby revolutionizing various aspects of business operations, including drug discovery.


By leveraging Salesforce Einstein AI, pharmaceutical companies can optimize the molecule scoring process through advanced analytics and predictive modeling. Here's how:


Salesforce Einstein AI Prediction Builder enables organizations to create custom AI models tailored to their specific needs. In the context of drug discovery, this tool can be utilized to develop predictive models that assess the likelihood of a molecule's success based on predefined criteria.


By analyzing vast datasets encompassing molecular properties, biological activity, safety profiles, and clinical outcomes, Prediction Builder can provide valuable insights into the potential efficacy and safety of drug candidates.


  • Data Integration and Modeling:

Developing an effective data model for molecule scoring with Salesforce Einstein AI requires integration of diverse datasets pertaining to molecular properties, biological assays, preclinical and clinical data, regulatory information, and more.

Through seamless integration with existing data sources and advanced modeling techniques, organizations can build comprehensive AI models that capture the multifaceted aspects of drug development. These models can then be trained to identify patterns, correlations, and predictors of drug success, facilitating more informed decision-making.

  • Real-time Insights and Decision Support:

One of the key advantages of leveraging Salesforce Einstein AI is the ability to derive real-time insights from dynamic datasets. By continuously analyzing incoming data streams from ongoing experiments, clinical trials, and regulatory updates, organizations can gain actionable insights into the progress of drug candidates.

This real-time visibility enables stakeholders to make data-driven decisions, prioritize resources effectively, and adapt strategies i
n response to emerging trends or challenges.

  • Automation and Efficiency:

By automating routine tasks and decision-making processes, Salesforce Einstein AI helps streamline drug discovery operations, reducing manual effort and accelerating time-to-insight. Tasks such as data aggregation, analysis, and reporting can be automated, allowing scientists and researchers to focus their efforts on high-value activities such as experimental design, hypothesis generation, and innovation.

Additionally, AI-driven insights enable proactive risk management and mitigation strategies, enhancing overall operational efficiency and productivity.



In the rapidly evolving landscape of drug discovery, the integration of AI technologies such as Salesforce Einstein holds immense potential to optimize operational processes and drive innovation. By harnessing the power of AI-driven analytics, predictive modeling, and real-time insights, pharmaceutical companies can enhance the efficiency and effectiveness of molecule scoring, ultimately expediting the discovery and development of novel therapeutics.


As organizations continue to embrace AI as a strategic enabler of innovation, the future of drug discovery promises to be characterized by greater precision, agility, and success in bringing life-saving treatments to market.


"Implementing Salesforce Einstein AI with Brick Lane: Your Path to Success"


Brick Lane is highly experienced in constructing AI analytical models, we are equipped to guide you towards success in implementing Salesforce Einstein AI. If you want to know more you can contact me on

How can AI optimize molecule scoring.jpeg
Learn More

How can AI optimize Molecule Scoring?

SF Einstein AI


Arrange a friendly 15 min chat with our talented architecture team. 

We'll Be In Touch Shortly...

bottom of page